Rocuronium-sugammadex use for electroconvulsive therapy in a hemodialysis patient: a case report-Reference-Cited by-同舟云学术

Rocuronium-sugammadex use for electroconvulsive therapy in a hemodialysis patient: a case report

Published:2016-10-10 Issue:1 Volume:2 Page:
ISSN:2363-9024
Container-title:JA Clinical Reports
language:en
Short-container-title:JA Clin Rep

Author:

Kurita Shigeaki^ORCID,Moriwaki Katsuyuki,Shiroyama Kazuhisa,Sanuki Mikako,Toyota Yukari,Takebayashi Minoru

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40981-016-0055-4.pdf

Reference18 articles.

1. Rabindranath KS, Butler JA, Macleod AM, Roderick P, Wallace SA, Daly C. Physical measures for treating depression in dialysis patients. Cochrane Database Syst Rev. 2005;18:CD004541.

2. MacEvilly M, Riordan D, Ryan JP, Unwin AR. Electroconvulsion therapy and the haemodialysis dependent patient. Ir J Med Sci. 1983;152:392–3.

3. Williams S, Ostroff R. Chronic renal failure, hemodialysis, and electroconvulsive therapy: a case report. J ECT. 2005;21:41–2.

4. Wille PD. Electroconvulsive therapy in a patient on chronic hemodialysis. Nephrol Nurs J. 2007;34:441–3.

5. Mirzakhani H, Welch CA, Eikermann M, Nozari A. Neuromuscular blocking agents for electroconvulsive therapy: a systematic review. Acta Anaesthesiol Scand. 2012;56:3–16.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Electroconvulsive Therapy in a Patient With Depression on Hemodialysis;The Journal of ECT;2022-05-05

2. Efficacy and Safety of Sugammadex for the Reversal of Rocuronium-Induced Neuromuscular Blockade in Patients with End-Stage Renal Disease: A Systematic Review and Meta-Analysis;Medicina;2021-11-17